Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Edgewise Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 140
- +12 vs. Q1 2024
- Shares held
- 101.6M
- +10.0M (+10.9%) vs. Q1 2024
- Total value
- $1.83B
- +$159.5M (+9.5%) vs. Q1 2024
- New holders
- 33
- 58 more added
- Sold out
- 21
- 30 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.82B |
| Q1 2026 | 214 | $3.72B |
| Q4 2025 | 199 | $3.02B |
| Q3 2025 | 173 | $1.82B |
| Q2 2025 | 179 | $1.56B |
| Q1 2025 | 193 | $2.32B |
| Q4 2024 | 201 | $2.64B |
| Q3 2024 | 177 | $2.71B |
| Q2 2024 | 140 | $1.83B |
| Q1 2024 | 129 | $1.67B |
| Q4 2023 | 116 | $871.4M |
| Q3 2023 | 85 | $392.2M |
| Q2 2023 | 95 | $538.8M |
| Q1 2023 | 85 | $443.1M |
| Q4 2022 | 90 | $594.1M |
| Q3 2022 | 94 | $633.5M |
| Q2 2022 | 78 | $405.7M |
| Q1 2022 | 72 | $523.5M |
| Q4 2021 | 58 | $769.4M |
| Q3 2021 | 48 | $795.8M |
| Q2 2021 | 46 | $1.03B |
| Q1 2021 | 31 | $1.48B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Edgewise Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 415,720 | $7.49M | 0.01% | +361,103+661.2% | Added |
| Woodline Partners LP | 421,604 | $7.59M | 0.07% | +16,472+4.1% | Added |
| ADAR1 Capital Management, LLC | 436,608 | $7.86M | 1.58% | +255,697+141.3% | Added |
| Dimensional Fund Advisors LP | 467,507 | $8.42M | 0.00% | +168,219+56.2% | Added |
| Sofinnova Investments, Inc. | 475,691 | $8.57M | 0.54% | +475,691 | New |
| Wellington Management Group LLP | 493,847 | $8.89M | 0.00% | +20,944+4.4% | Added |
| Northern Trust Corp | 508,691 | $9.16M | 0.00% | +9,171+1.8% | Added |
| Balyasny Asset Management LLC | 528,594 | $9.52M | 0.02% | +528,594 | New |
| Charles Schwab Investment Management Inc | 571,197 | $10.3M | 0.00% | +74,035+14.9% | Added |
| Parkman Healthcare Partners LLC | 574,517 | $10.3M | 1.41% | −79,136−12.1% | Reduced |
| Opaleye Management Inc. | 580,000 | $10.4M | 2.39% | −85,000−12.8% | Reduced |
| Granahan Investment Management Inc | 710,723 | $12.8M | 0.51% | +102,711+16.9% | Added |
| MPM Oncology Impact Management LP | 740,661 | $13.3M | 2.07% | +299,402+67.9% | Added |
| Artal Group S.A. | 811,718 | $14.6M | 0.38% | 00.0% | Unchanged |
| American Century Companies Inc | 860,067 | $15.5M | 0.01% | +300,733+53.8% | Added |
| Millennium Management LLC | 1,145,506 | $20.6M | 0.02% | +613,251+115.2% | Added |
| EcoR1 Capital, LLC | 1,250,385 | $22.5M | 0.69% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 1,260,392 | $22.7M | 0.22% | −7,427−0.6% | Reduced |
| Bellevue Group AG | 1,428,929 | $25.7M | 0.42% | +1,428,929 | New |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,481,146 | $26.7M | 0.10% | −1,858,000−55.6% | Reduced |
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $28.0M | 34.03% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 1,622,741 | $29.2M | 0.01% | −125,103−7.2% | Reduced |
| State Street Corp | 1,665,095 | $30.0M | 0.00% | +453,619+37.4% | Added |
| Geode Capital Management, LLC | 1,672,653 | $30.1M | 0.00% | +302,756+22.1% | Added |
| VR Adviser, LLC | 1,818,182 | $32.7M | 2.09% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,856,417 | $33.4M | 0.81% | −463,229−20.0% | Reduced |
| TCG Crossover Management, LLC | 2,272,728 | $40.9M | 4.27% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 2,325,449 | $41.9M | 1.60% | −120,924−4.9% | Reduced |
| Citadel Advisors LLC | 2,349,174 | $42.3M | 0.04% | −370,117−13.6% | Reduced |
| Janus Henderson Group PLC | 2,607,299 | $46.9M | 0.03% | +801,987+44.4% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,874,586 | $51.8M | 0.86% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 3,006,534 | $54.1M | 3.15% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 3,731,067 | $67.2M | 3.14% | +427,500+12.9% | Added |
| Vanguard Group Inc | 4,508,166 | $81.2M | 0.00% | +490,733+12.2% | Added |
| FMR LLC | 4,780,563 | $86.1M | 0.01% | −1,585,161−24.9% | Reduced |
| Baker Bros. Advisors LP | 5,840,059 | $105.2M | 1.34% | 00.0% | Unchanged |
| BlackRock Inc. | 6,015,711 | $108.3M | 0.00% | +848,705+16.4% | Added |
| Novo Holdings A/S | 6,344,430 | $114.3M | 6.16% | +6,344,430 | New |
| Ra Capital Management, L.P. | 8,909,091 | $160.5M | 2.12% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 15,021,721 | $270.5M | 5.77% | 00.0% | Unchanged |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −175,901−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −126,332−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −103,208−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −74,511−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −60,881−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −45,400−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −28,418−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| Castleview Partners, LLC | 0 | $0 | 0.00% | −16,204−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −14,216−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,049−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −13,615−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −13,042−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −12,665−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −10,814−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −8,009−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,081−100.0% | Sold out |
| Financial Synergies Wealth Advisors, Inc. | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |